Ruth E. Thom
Salisbury, ENG SP40JQ, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Future applications of host direct therapies for infectious disease treatment.
Journal: Frontiers in immunology
Published: May 22, 2024
Assessment of CD200R Activation in Combination with Doxycycline in a Model of Melioidosis.
Journal: Microbiology spectrum
Published: May 18, 2023
Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms.
Journal: Frontiers in cellular and infection microbiology
Published: November 11, 2021
Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms.
Journal: Frontiers in cellular and infection microbiology
Published: June 10, 2021
Human Diversity of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Class I Alleles and Ebola Virus Disease Outcomes.
Journal: Emerging infectious diseases
Published: December 22, 2020
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study.
Journal: The Lancet. Infectious diseases
Published: May 18, 2020
Survival and persistence of Nipah virus in blood and tissue culture media.
Journal: Emerging microbes & infections
Published: December 12, 2019
Development of national consensus statements on food labelling interpretation and protein allocation in a low phenylalanine diet for PKU.
Journal: Orphanet journal of rare diseases
Published: February 19, 2018
Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015.
Journal: The Journal of infectious diseases
Published: September 18, 2016
Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model.
Journal: PloS one
Published: August 25, 2016
Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
Journal: PLoS medicine
Published: April 06, 2016
Last Updated: 09/26/2026